Zevia Exceeds Q2 Sales Outlook, Eyes $158-$163M Full-Year Sales Amidst Innovation and Distribution Gains
ByAinvest
Thursday, Aug 7, 2025 6:57 am ET1min read
MMM--
The company's second-quarter net sales improved by 10.1% to $44.5 million, driven by a 14.3% increase in volume, primarily from expanded distribution at Walmart and one customer in the drug channel, as well as higher price realization. Gross profit margin improved to 48.7%, up 6.8 percentage points year-over-year. Selling and marketing expenses decreased to 30.0% of net sales, while general and administrative expenses increased slightly to 18.2%.
Zevia PBC expects full-year net sales to be in the range of $158 million to $163 million, exceeding its previous guidance of $157 million to $160 million. The company's outlook for adjusted EBITDA loss for 2025 has been revised to between $7 million and $9 million, reflecting continued benefit from cost-savings initiatives and higher costs associated with tariffs.
The company's balance sheet remains strong, with $26.3 million in cash and cash equivalents and no outstanding debt. Zevia PBC will host a conference call to discuss its results at 4:30 p.m. Eastern Time on August 6, 2025. Investors and other interested parties can listen to the webcast via the Investor Relations section of Zevia's website at https://investors.zevia.com/.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TW2UX:0-zevia-pbc-expected-to-post-a-loss-of-4-cents-a-share-earnings-preview/
[2] https://www.morningstar.com/news/business-wire/20250806845667/zevia-announces-second-quarter-2025-results
WMT--
ZVIA--
Zevia PBC maintains its $158M-$163M full-year sales outlook, exceeding Q2 2025 expectations with net sales and adjusted EBITDA. CEO Amy E. Taylor is pleased with progress on strategic initiatives, noting the company's first profitable quarter. The company is accelerating innovation and distribution gains, with a focus on expanding its presence in the low-calorie beverage market.
Zevia PBC (ZVIA) has reported strong financial results for the second quarter of 2025, surpassing market expectations. The company's net sales grew by 10.1% to $44.5 million, while adjusted EBITDA turned positive at $0.2 million, marking the company's first profitable quarter. CEO Amy E. Taylor expressed satisfaction with the progress on strategic initiatives, highlighting the company's focus on innovation and distribution gains.The company's second-quarter net sales improved by 10.1% to $44.5 million, driven by a 14.3% increase in volume, primarily from expanded distribution at Walmart and one customer in the drug channel, as well as higher price realization. Gross profit margin improved to 48.7%, up 6.8 percentage points year-over-year. Selling and marketing expenses decreased to 30.0% of net sales, while general and administrative expenses increased slightly to 18.2%.
Zevia PBC expects full-year net sales to be in the range of $158 million to $163 million, exceeding its previous guidance of $157 million to $160 million. The company's outlook for adjusted EBITDA loss for 2025 has been revised to between $7 million and $9 million, reflecting continued benefit from cost-savings initiatives and higher costs associated with tariffs.
The company's balance sheet remains strong, with $26.3 million in cash and cash equivalents and no outstanding debt. Zevia PBC will host a conference call to discuss its results at 4:30 p.m. Eastern Time on August 6, 2025. Investors and other interested parties can listen to the webcast via the Investor Relations section of Zevia's website at https://investors.zevia.com/.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TW2UX:0-zevia-pbc-expected-to-post-a-loss-of-4-cents-a-share-earnings-preview/
[2] https://www.morningstar.com/news/business-wire/20250806845667/zevia-announces-second-quarter-2025-results

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet